Revised european task force diagnostic criteria for arrhythmogenic cardiomyopathy (2023)
https://doi.org/10.51922/2616-633X.2024.8.1.2168
Abstract
In order to improve the diagnosis of arrhythmogenic cardiomyopathy (ACM) in 2023, leading European experts validated new recommendations and a consensus report with augmented criteria for diagnosis of ACM (based on modified ITF criteria 2010 and Padua criteria 2020). The article highlights the crucial aspects of diagnosis and practical experience of novel criteria for the recognition of various phenotypes of ACM.
About the Authors
S. Komissarova
State Institution Republican Scientific and Practical Centre «Cardiology»
Belarus
Belarus
Minsk
N. Rineiska
State Institution Republican Scientific and Practical Centre «Cardiology»
Belarus
Belarus
Minsk
A. Efimova
State Institution Republican Scientific and Practical Centre «Cardiology»
Belarus
Belarus
Minsk
N. Chakova
Institute of Genetics and Cytology of Belarus National Academy of Sciences
Belarus
Belarus
Minsk
References
1. Arbelo E., Protonotarios A., Gimeno J.R., et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J, 2023, vol. 44(37), pp. 3503-3626. doi: 10.1093/eurheartj/ehad194.
2. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J, 2010, vol. 31(7), pp. 806-814. doi: 10.1093/eurheartj/ehq025.
3. Corrado D., Perazzolo Marra M., Zorzi A., et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol, 2020, vol. 319, pp. 106-114. doi: 10.1016/j.ijcard.2020.06.005.
4. Corrado D., Anastasakis A., Basso C., Bauce B., Blomström-Lundqvist C., et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol, 2024, Jan 15:395:131447. doi: 10.1016/j.ijcard.2023.131447.
5. Corrado D., van Tintelen P.J., McKenna W.J., et al. International Experts. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414-1429. doi: 10.1093/eurheartj/ehz669.
6. Richards S., Aziz N., Bale S., et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, vol. 17(5), pp. 405-424. doi: 10.1038/gim.2015.30.
7. Wang W., Murray B., Tichnell C., Gilotra N.A., Zimmerman S.L., et al. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. Europace, 2022, vol. 24(2), pp. 268-277. doi: 10.1093/europace/euab183.
8. Verstraelen T.E., van Lint F.H.M., Bosman L.P., de Brouwer R., et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction. Eur Heart J, 2021, vol. 42(29), pp. 2842-2850. doi: 10.1093/eurheartj/ehab294.
9. Corrado D., Zorzi A., Cipriani A., Bauce B., Bariani R., Beffagna G., et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy. J Am Heart Assoc, 2021, vol. 10(18), pp. e021987. doi: 10.1161/JAHA.121.021987.
Review
For citations:
Komissarova S., Rineiska N., Efimova A., Chakova N. Revised european task force diagnostic criteria for arrhythmogenic cardiomyopathy (2023). Emergency Cardiology and Cardiovascular Risks journal. 2024;8(1):2168-2180. (In Russ.) https://doi.org/10.51922/2616-633X.2024.8.1.2168
Views:
23
Email this article 